1. Home
  2. LRMR vs CCRD Comparison

LRMR vs CCRD Comparison

Compare LRMR & CCRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • CCRD
  • Stock Information
  • Founded
  • LRMR N/A
  • CCRD 1973
  • Country
  • LRMR United States
  • CCRD United States
  • Employees
  • LRMR N/A
  • CCRD N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • CCRD
  • Sector
  • LRMR Health Care
  • CCRD
  • Exchange
  • LRMR Nasdaq
  • CCRD Nasdaq
  • Market Cap
  • LRMR 183.8M
  • CCRD 192.4M
  • IPO Year
  • LRMR N/A
  • CCRD N/A
  • Fundamental
  • Price
  • LRMR $1.91
  • CCRD $19.09
  • Analyst Decision
  • LRMR Strong Buy
  • CCRD Hold
  • Analyst Count
  • LRMR 9
  • CCRD 1
  • Target Price
  • LRMR $19.00
  • CCRD $21.00
  • AVG Volume (30 Days)
  • LRMR 1.0M
  • CCRD 20.3K
  • Earning Date
  • LRMR 05-08-2025
  • CCRD 05-01-2025
  • Dividend Yield
  • LRMR N/A
  • CCRD N/A
  • EPS Growth
  • LRMR N/A
  • CCRD 67.50
  • EPS
  • LRMR N/A
  • CCRD 0.67
  • Revenue
  • LRMR N/A
  • CCRD $57,399,000.00
  • Revenue This Year
  • LRMR N/A
  • CCRD $9.82
  • Revenue Next Year
  • LRMR N/A
  • CCRD N/A
  • P/E Ratio
  • LRMR N/A
  • CCRD $28.49
  • Revenue Growth
  • LRMR N/A
  • CCRD 2.49
  • 52 Week Low
  • LRMR $1.61
  • CCRD $11.12
  • 52 Week High
  • LRMR $11.20
  • CCRD $24.97
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 39.39
  • CCRD 49.71
  • Support Level
  • LRMR $1.76
  • CCRD $17.91
  • Resistance Level
  • LRMR $1.91
  • CCRD $19.00
  • Average True Range (ATR)
  • LRMR 0.17
  • CCRD 1.18
  • MACD
  • LRMR 0.03
  • CCRD 0.14
  • Stochastic Oscillator
  • LRMR 46.15
  • CCRD 85.00

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About CCRD CoreCard Corporation

CoreCard Corp is engaged in the business of providing technology solutions and processing services to the financial technology and services market. It designs, develops and markets a comprehensive suite of software solutions to program managers, accounts receivable businesses, financial institutions, retailers and processors to manage their credit and debit cards, prepaid cards, private label cards, fleet cards, buy now pay later programs, loyalty programs and accounts receivable and loan transactions. The CoreCard software platform and modules include CoreENGINE, CoreISSUE, CoreFRAUD, CoreCOLLECT, CoreAPP, CoreMONEY and CoreACQUIRE. Its customers are located in the U.S, European Union and the Middle East of which key revenue is derived from the U.S.

Share on Social Networks: